GlassScriptPhysician profile
Gerald J Fay
NPI 1538200936
$825.90
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
See the full distribution for Geriatric Medicine (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $612 · 2020: $214.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $126.54 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $123.27 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $72.61 | 2019-2020 | |
| Glaxosmithkline, LLC. | $69.29 | 2019-2020 | |
| Pfizer INC. | $56.28 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $44.48 | 2019 | |
| Astellas Pharma US INC | $43.68 | 2019-2020 | |
| Lilly USA, LLC | $37.47 | 2019 | |
| Janssen Pharmaceuticals, INC | $34.96 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $34.55 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $30.11 | 2019-2020 | |
| Daiichi Sankyo INC. | $23.36 | 2019 | |
| Novo Nordisk INC | $22.92 | 2020 | |
| Hikma Pharmaceuticals USA | $21.25 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $19.75 | 2020 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $17.24 | 2019 | |
| Allergan, INC. | $12.76 | 2019 | |
| Philips North America LLC | $12.63 | 2019 | |
| Sanofi Pasteur INC. | $11.61 | 2019 | |
| Amarin Pharma, INC. | $11.14 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gerald Fay listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.